Wanbury
₹148.65
-6.3 (-4.07%)
24 May, 2024 04:49 BSE: 524212
NSE: WANBURYISIN: INE107F01022
Start SIP in Wanbury
Start SIPWanbury Performance
Day Range
- Low 148
- High 155
52 Week Range
- Low 43
- High 179
- Open Price152
- Previous Close155
- Volume82931
Wanbury Financials
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 139 | 145 | 144 | 146 | 133 |
| Operating Expenses Qtr Cr | 121 | 124 | 127 | 133 | 119 |
| Operating Profit Qtr Cr | 18 | 21 | 17 | 13 | 14 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 | 3 |
| Interest Qtr Cr | 7 | 8 | 8 | 6 | 8 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 8 | 10 | 7 | 5 | 1 |
Wanbury Technicals
EMA & SMA
Current Price
₹148.65
-6.3 (-4.07%)
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹150.16
- 50 Day
- ₹149.28
- 100 Day
- ₹141.56
- 200 Day
- ₹121.90
- 20 Day
- ₹148.43
- 50 Day
- ₹148.29
- 100 Day
- ₹148.38
- 200 Day
- ₹114.90
Wanbury Resistance and Support
PIVOT
₹150.45
| Resistance | |
|---|---|
| First Resistance | 152.85 |
| Second Resistance | 157.05 |
| Third Resistance | 159.45 |
| RSI | 48.78 |
| MFI | 26.63 |
| MACD Single Line | -0.46 |
| MACD | 0.78 |
| Support | |
|---|---|
| First Support | 146.25 |
| Second Support | 143.85 |
| Third Supoort | 139.65 |
Wanbury Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 106,783 | 8,697,475 | 81.45 |
| Week | 184,614 | 13,332,809 | 72.22 |
| 1 Month | 107,929 | 8,121,657 | 75.25 |
| 6 Month | 118,346 | 11,015,628 | 93.08 |
Wanbury Result Highlights
Wanbury Synopsis
NSE-Medical-Generic Drugs
Wanbury is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 499.65 Cr. and Equity Capital is Rs. 32.71 Cr. for the Year ended 31/03/2023. Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455.| Market Cap | 487 |
| Sales | 576 |
| Shares in Float | 1.96 |
| No of funds | 5 |
| Yield |
| Book Value | 17.54 |
| U/D Vol ratio | 0.8 |
| LTDebt / Equity | 293 |
| Alpha | 0.39 |
| Beta | 0.79 |
Wanbury Shareholding Pattern
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 39.79% | 39.79% | 39.8% | 39.84% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.18% | |||
| Financial Institutions/ Banks | ||||
| Individual Investors | 41.81% | 39.09% | 39.53% | 38.42% |
| Others | 18.22% | 21.12% | 20.67% | 21.74% |
Wanbury Management
| Name | Designation |
|---|---|
| Mr. K Chandran | Vice Chairman & Whole Time Dir |
| Mr. N K Puri | Ind. Non-Executive Director |
| Ms. Pallavi P Shedge | Ind. Non-Executive Director |
Wanbury Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Wanbury Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-16 | Audited Results | |
| 2024-01-24 | Quarterly Results | |
| 2023-10-20 | Quarterly Results & Preferential issue | Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company. |
| 2023-08-11 | Quarterly Results | |
| 2023-06-09 | Audited Results | (Revised) |
Wanbury FAQs
What is Share Price of Wanbury ?
Wanbury share price is ₹148 As on 24 May, 2024 | 04:35
What is the Market Cap of Wanbury ?
The Market Cap of Wanbury is ₹486.8 Cr As on 24 May, 2024 | 04:35
What is the P/E ratio of Wanbury ?
The P/E ratio of Wanbury is 8.7 As on 24 May, 2024 | 04:35
What is the PB ratio of Wanbury ?
The PB ratio of Wanbury is 17.4 As on 24 May, 2024 | 04:35